Author:
Bray Whitney M.,Bivona Cory,Rockey Michelle,Henry Dave,Grauer Dennis,Abhyankar Sunil,Aljitawi Omar,Ganguly Siddhartha,McGuirk Joseph,Singh Anurag,Lin Tara L.
Funder
National Cancer Institute of the National Institutes of Health
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference10 articles.
1. Meyerhardt JA, Tepper JE, Niedzwiecki D et al (2004) Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114. J Clin Oncol 22:648–657
2. Colleoni M, Li S, Gelber RD et al (2005) Relation between chemotherapy dose, oestrogen receptor expression, and body-mass index. Lancet 366:1108–1110
3. Rosner GL, Hargis JB, Hollis DR et al (1996) Relationship between toxicity and obesity in women receiving adjuvant chemotherapy for breast cancer: results from cancer and leukemia group B study 8541. J Clin Oncol 14:3000–3008
4. Griggs JJ, Manqu PB, Anderson H et al (2012) Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol 30(99):1–10
5. Burhani M, Dave MJ, Venugopal P et al (2013) Influence of BMI on outcomes of high-dose cytarabine and mitoxantrone induction therapy for AML. [Abstract] J Clin Oncol 31 (Suppl; abstr 7106)
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献